Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Spatial and Temporal Virus Load Dynamics of SARS-CoV-2: A Single-Center Cohort Study.
Alidjinou EK, Poissy J, Ouafi M, Caplan M, Benhalima I, Goutay J, Tinez C, Faure K, Chopin MC, Yelnik C, Lambert M, Hober D, Preau S; The Lille COVID Research Network (LICORNE); Nseir S, Engelmann I. Alidjinou EK, et al. Diagnostics (Basel). 2021 Mar 3;11(3):427. doi: 10.3390/diagnostics11030427. Diagnostics (Basel). 2021. PMID: 33802451 Free PMC article.
Assessment of pulmonary arterial circulation 3 months after hospitalization for SARS-CoV-2 pneumonia: Dual-energy CT (DECT) angiographic study in 55 patients.
Remy-Jardin M, Duthoit L, Perez T, Felloni P, Faivre JB, Fry S, Bautin N, Chenivesse C, Remy J, Duhamel A. Remy-Jardin M, et al. Among authors: bautin n. EClinicalMedicine. 2021 Apr;34:100778. doi: 10.1016/j.eclinm.2021.100778. Epub 2021 Mar 30. EClinicalMedicine. 2021. PMID: 33817609 Free PMC article.
Severity and phenotypes of dyspnea in asthma: Impact of comorbidities.
Bousso A, Chuffart C, Leroy M, Gicquello A, Cottereau A, Hennegrave F, Beurnier A, Stoup T, Pereira S, Morelot-Panzini C, Taille C, Bautin N, Fry S, Perez T, Garcia G, Chenivesse C. Bousso A, et al. Among authors: bautin n. Respir Med. 2023 May 20:107276. doi: 10.1016/j.rmed.2023.107276. Online ahead of print. Respir Med. 2023. PMID: 37217082
Improvement of exertional dyspneoa in patients with chronic obstructive pulmonary disease and severe allergic asthma responding to omalizumab.
Pereira S, Verhille J, Cailliau E, Bonniaud P, Devouassoux G, Fry S, Guilleminault L, Khayath N, Leroyer C, Chenivesse C, Bautin N. Pereira S, et al. Among authors: bautin n. Clin Exp Allergy. 2023 Dec;53(12):1298-1301. doi: 10.1111/cea.14392. Epub 2023 Sep 13. Clin Exp Allergy. 2023. PMID: 37705326 No abstract available.
34 results